INTERIM EVALUATION OF THE ITALIAN MEDICINES USE REVIEW (I-MUR) PROVIDED BY COMMUNITY PHARMACISTS USING ASTHMA AS A MODEL.
- At: 2015 FIP Congress in Düsseldorf (Germany)
- Type: Poster
- By: MANFRIN, Andrea (Medway School of Pharmacy, Pharmacy, Chatham, United Kingdom)
- Co-author(s): Andrea Manfrin
Achievement and maintenance of asthma control is a paramount, but in many patients it is not achieved or suboptimal. Costs of asthma have been related to control showing the total cost per patient ranges from €509 (uncontrolled) to €2.281 (controlled).
This is a 9-month cluster randomized control trial with data collection before, during and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.